Roflumilast, a phosphodiesterase-4 inhibitor, induces phagocytic activity in Greek COPD patients.

Konstantinos Porpodis,Kalliopi Domvri, Paul Zarogoulidis,Dimitrios Petridis,Katerina Tsirgogianni,Antonis Papaioannou, Olga Hatzizisi,Ioannis Kioumis, Alexandra Liaka, Violeta Kikidaki,Sofia Lampaki,John Organtzis,Konstantinos Zarogoulidis

INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE（2015）

Cited 4|Views17

No score

Abstract

Although the number of patients in this study was limited, our results indicate that roflumilast induces phagocytic activity, which improves lung function.

Translated text

Key words

COPD,phosphodiesterase-4 inhibitors,roflumilast

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined